Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis

被引：0
|
作者：
Hyungwoo Cho
Min-Hee Ryu
Kyu-pyo Kim
Baek-Yeol Ryoo
Sook Ryun Park
Bum Soo Kim
In-Seob Lee
Hee-Sung Kim
Moon-Won Yoo
Jeong Hwan Yook
Seong Tae Oh
Byung Sik Kim
Yoon-Koo Kang
机构：
[1] University of Ulsan College of Medicine,Department of Internal Medicine, Asan Medical Center
[2] University of Ulsan College of Medicine,Department of Oncology, Asan Medical Center
[3] University of Ulsan College of Medicine,Department of Surgery, Asan Medical Center
来源：
Gastric Cancer | 2017年 / 20卷
关键词：
Gastric cancer; Chemotherapy; Peritoneal metastasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：970 / 977
页数：7
相关论文
共 50 条
  • [21] Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: A phase II study
    Orditura, M.
    Aurilio, G.
    Galizia, G.
    Carlomagno, C.
    Lieto, E.
    Vecchione, L.
    Martinelli, E.
    De Placido, S.
    Catalano, G.
    Ciardiello, F.
    De Vita, F.
    ANNALS OF ONCOLOGY, 2006, 17 : XI52 - XI52
  • [22] A phase II study of preoperative docetaxel, cisplatin, and capecitabine in patients with gastric carcinoma.
    Voon, Pei-Jye
    Soe, Mu-Yar
    Zee, Ying Kiat
    Chuah, Benjamin
    Lim, Robert S. C.
    Shabbir, Asim
    So, Jimmy
    Yong, Wei-Peng
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [23] Phase I open label trial of intraperitoneal paclitaxel (IPP) in combination with intravenous cisplatin (C) and oral capecitabine (X) in patients with advanced gastric cancer and peritoneal metastases.
    Vatandoust, Sina
    Bright, Tim I.
    Roy, Amitesh Chandra
    Klevansky, Myron
    Bull, Jeff
    Karapetis, Christos Stelios
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [24] Phase II study of trastuzumab in combination with capecitabine and oxaliplatin in patients with advanced gastric cancer
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Park, Young Soo
    Park, Sook Ryun
    Kim, Jong Gwang
    Han, Hye-Suk
    Chung, Ik-Joo
    Song, Eun-Kee
    Lee, Kyung Hee
    Kang, Seok Yun
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [25] Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer
    J H Baek
    J G Kim
    S B Jeon
    Y S Chae
    D H Kim
    S K Sohn
    K B Lee
    Y J Choi
    H J Shin
    J S Chung
    G J Cho
    H Y Jung
    W Yu
    British Journal of Cancer, 2006, 94 : 1407 - 1411
  • [26] Phase I study of biweekly intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel for gastric cancer with peritoneal metastasis
    Ishigami, H.
    Kitayama, J.
    Kaisaki, S.
    Yamaguchi, H.
    Yamashita, H.
    Emoto, S.
    Nagawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [27] Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer
    Baek, J. H.
    Kim, J. G.
    Jeon, S. B.
    Chae, Y. S.
    Kim, D. H.
    Sohn, S. K.
    Lee, K. B.
    Choi, Y. J.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Jung, H. Y.
    Yu, W.
    BRITISH JOURNAL OF CANCER, 2006, 94 (10) : 1407 - 1411
  • [28] Phase I Study of Biweekly Intravenous Paclitaxel plus Intraperitoneal Cisplatin and Paclitaxel for Gastric Cancer with Peritoneal Metastasis
    Ishigami, Hironori
    Kitayama, Joji
    Kaisaki, Shoichi
    Yamaguchi, Hironori
    Yamashita, Hiroharu
    Emoto, Shigenobu
    Nagawa, Hirokazu
    ONCOLOGY, 2010, 79 (3-4) : 269 - 272
  • [29] Phase II study with docetaxel (D), cisplatin (C), and continuous capecitabine (CAP) combination (TCX) in advanced gastric cancer: Preliminary data.
    Pericay, C.
    Losa, F.
    Pisa, A.
    Alfaro, J.
    Cirera, L.
    Salud, A.
    Falco, E.
    Dotor, E.
    Vicente, P.
    Casado, E.
    Oliva, J. C.
    Saigi, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer
    Lee, K. -W.
    Park, S. R.
    Oh, D. -Y.
    Park, Y. -I.
    Khosravan, R.
    Lin, X.
    Lee, S. -Y.
    Roh, E. -J.
    Valota, O.
    Lechuga, M. J.
    Bang, Y. -J.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1547 - 1558
12345